Duchenne Muscular Dystrophy Treatment Market Share

Statistics for the 2023 & 2024 Duchenne Muscular Dystrophy Treatment market share, created by Mordor Intelligence™ Industry Reports. Duchenne Muscular Dystrophy Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Genetic Disorder Drugs Research Duchenne Muscular Dystrophy Treatment Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Duchenne Muscular Dystrophy Treatment Industry

The Duchenne muscular dystrophy treatment market is moderately fragmented and consists of several major players. Some companies currently dominating the market are Nippon Shinyaku Co. Ltd, ITALFARMACO SpA, PTC Therapeutics, Santhera Pharmaceuticals Holding AG, and Sarepta Therapeutics Inc.

Duchenne Muscular Dystrophy Treatment Market Leaders

  1. NIPPON SHINYAKU CO., LTD. (NS Pharma Inc.)

  2. ITALFARMACO S.p.A.

  3. PTC Therapeutics

  4. Santhera Pharmaceuticals

  5. Sarepta Therapeutics

*Disclaimer: Major Players sorted in no particular order

Duchenne Muscular Dystrophy Treatment Market Concentration

Duchenne Muscular Dystrophy Treatment Market Report Snapshots

Duchenne Muscular Dystrophy Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)